Denchev Stefan V, Simova Iana I, Matveev Mikhail G
Clinic of Cardiology, University Hospital Aleksandrovska, Sofia, Bulgaria.
Blood Press Monit. 2007 Oct;12(5):329-33. doi: 10.1097/MBP.0b013e32813fa39e.
To evaluate the SCHILLER BR-102 plus (Schiller AG, Baar, Switzerland) noninvasive ambulatory blood pressure recorder according to the International Protocol for validation of blood pressure measuring devices in adults introduced by the Working Group on Blood Pressure Monitoring of the European Society of Hypertension.
One SCHILLER BR-102 plus blood pressure recorder was tested by a validation team, consisting of three persons: two observers (nurses) and a doctor, acting as supervisor and 'expert'. The European Society of Hypertension International Protocol comprises two phases. Fifteen participants were recruited for the first phase and, following a successful test, a further 18 persons (giving a total of 33) were recruited additionally. For phase 1, five of the 15 participants had systolic blood pressure and diastolic blood pressure in each of the ranges: low, medium and high. For phase 2, 11 of the 33 participants (including the first 15 participants) had systolic blood pressure and diastolic blood pressure in each of the ranges. The mercury standard for validation was preferred over the optional Sphygmocorder. Because the SCHILLER BR-102 plus has the oscillometric method as backup to the basic auscultatory measurement, both systems of measurement were subjected to individual validations.
Results obtained show that the SCHILLER BR-102 plus noninvasive ambulatory blood pressure recorder meets all the requirements specified in the International Protocol for both oscillometric and auscultatory methods.
On the basis of these results, the SCHILLER BR-102 plus can be recommended for ambulatory blood pressure measurement in clinical practice using both auscultatory and oscillometric modes.
根据欧洲高血压学会血压监测工作组推出的国际协议，对SCHILLER BR - 102 plus（瑞士巴阿的席勒股份公司）无创动态血压记录仪进行评估，以验证其在成人血压测量设备中的有效性。
一个验证团队对一台SCHILLER BR - 102 plus血压记录仪进行了测试，该团队由三人组成：两名观察员（护士）和一名医生，医生担任监督者和“专家”。欧洲高血压学会国际协议包括两个阶段。第一阶段招募了15名参与者，在测试成功后，又额外招募了18人（共33人）。在第一阶段，15名参与者中有5人在低、中、高每个血压范围内都有收缩压和舒张压数据。在第二阶段，33名参与者（包括最初的15名参与者）中有11人在每个血压范围内都有收缩压和舒张压数据。验证时首选汞标准而非可选的脉搏血压记录仪。由于SCHILLER BR - 102 plus以示波法作为基本听诊测量的备用方法，因此对两种测量系统都进行了单独验证。
获得的结果表明，SCHILLER BR - 102 plus无创动态血压记录仪在示波法和听诊法方面均符合国际协议规定的所有要求。
基于这些结果，SCHILLER BR - 102 plus可推荐用于临床实践中采用听诊和示波模式的动态血压测量。
